Les meilleurs doctors traitant la maladie suivante : Épilepsie - TOP -154 des médecins

Dr. Panos Vrentas was born on 02/08/1962 and is married to Panagiotopoulou V., Psychiatrist - Director of the Psychological Health Center of Tripoli with whom they have two children. In 1979 he began his studies at the Medical School of the Aristotle University of Thessaloniki and graduated in 1986. He received his specialty as a neurologist in 1994 from the General Hospital of Athens. He received his diploma from the University College of Clinical Neurology in London in 1995. He has been trained in neurological hospitals in the USA, TORONTO and CANADA. When he was in the army he served as a military doctor in the special forces. He was Senior Secretary in Neurology at Leeds General Practice and in the Visitor Registry for Motor Disorders and Neurology at London National Hospital. (1996-1997).In 1997-2001 he was the head of a clinic for movement disorders at the General Hospital of Athens.  From 2001 to 2008 he was a doctor at the hospital in Tripoli. Since 2008 he has his own doctor's office in Tripoli and Sparta and works as a freelancer. From 2013 until today he is a Neurologist at the PALLADION Clinic and Medical Wellness.Finally, he is a member of the American Academy of Neurology, the Royal College of Physicians, the Movement Disorders Society, and the American Academy of Anti-Aging Medicine.

Neurologue pédiatrique spécialisé dans l'épilepsie, les maux de tête, les troubles du sommeil, la neurologie infantile et le suivi du développement. Diplôme de médecine de l'université d'Istanbul Cerrahpaşa en 2006 et formation d'assistant mineur en neurologie infantile à l'université Medipol d'Istanbul en 2017. A suivi une formation de médecin spécialiste à l'hôpital d'État de Şanlıurfa Suruç en 2012 et à l'hôpital de formation et de recherche Gaziosmanpaşa d'Istanbul en 2017. Titulaire de diverses certifications, notamment la qualification Denver 2 Developmental Screening Test, la certification de praticien du Neotonal Resuscitation Program et divers cours de neurologie infantile, d'épilepsie, de neuro-immunologie, d'EMG et de génétique de base. Membre de la Société turque de neurologie infantile.

Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

Education

• 1985 – Bachelor of Medicine and Surgery , Complutense University of Madrid.
• 1986-1989 – Specialization in Neurology , Hospital 12 de Octubre, Madrid.
• 1991–1993 – Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
• 1997 – Certification of the American Board of Clinical Neurophysiology .

Professional experience

• 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
• 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
• Since 1998 – Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
• 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
• 2022 – Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

Membership in professional societies

• Since 1991 – Member of the American Academy of Neurology (AAN).
• Since 1991 – Member of the American Epilepsy Society (AES).
• Since 1996 – Member of the American Society of Clinical Neurophysiology .
• Since 1988 – Member of the Spanish Society of Neurology .
• Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
• Since 2006 – Member of the editorial committee and the WFN web portal .
• Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
• Since 2009 – Member of the EFNS Educational Courses Committee.
• 2007–2009 – Member of the EFNS Scientific Committee .
• 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
• 2004–2007 – Delegate of Spain to the EFNS .
• 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

Outstanding Achievements

Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.

Chef du service de neurologie, neurologue

Chef du département de neurologie, neurologue

Directeur de la clinique de neurologie avec neurologie expérimentale, chef de centre CC15>